| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/CGT.2008.8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/cgt.2008.8 |
| P698 | PubMed publication ID | 18369380 |
| P5875 | ResearchGate publication ID | 5483910 |
| P2093 | author name string | J Nemunaitis | |
| A W Tong | |||
| P2860 | cites work | Micromanagement during the innate immune response | Q80370314 |
| Proof concept for clinical justification of network mapping for personalized cancer therapeutics | Q80413450 | ||
| Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China | Q81457086 | ||
| Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA | Q81547115 | ||
| MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia | Q21092263 | ||
| "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron | Q21145225 | ||
| Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54 | Q21146051 | ||
| Principles of microRNA-target recognition | Q21146368 | ||
| Prediction and preliminary validation of oncogene regulation by miRNAs | Q21262991 | ||
| Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs | Q24299641 | ||
| The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells | Q24319096 | ||
| The role of microRNA genes in papillary thyroid carcinoma | Q24535848 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| TarBase: A comprehensive database of experimentally supported animal microRNA targets | Q24537513 | ||
| Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| MicroRNA fingerprints during human megakaryocytopoiesis | Q24546361 | ||
| microRNAs exhibit high frequency genomic alterations in human cancer | Q24546369 | ||
| MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues | Q24559264 | ||
| MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias | Q24564008 | ||
| Requirement of bic/microRNA-155 for normal immune function | Q24656120 | ||
| Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation | Q24658400 | ||
| Micro-RNAs: small is plentiful | Q24672426 | ||
| Extensive post-transcriptional regulation of microRNAs and its implications for cancer | Q24672862 | ||
| Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development | Q24674155 | ||
| Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation | Q24679746 | ||
| MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms | Q24680714 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia | Q28206302 | ||
| Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer | Q28211530 | ||
| Patterns of known and novel small RNAs in human cervical cancer | Q28235627 | ||
| let-7 microRNA functions as a potential growth suppressor in human colon cancer cells | Q28237683 | ||
| The let-7 microRNA represses cell proliferation pathways in human cells | Q28240833 | ||
| P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression | Q28242438 | ||
| Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 | ||
| Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin | Q28246239 | ||
| Characterization of colorectal-cancer-related cDNA clones obtained by subtractive hybridization screening | Q28248611 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells | Q28249223 | ||
| Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies | Q28252216 | ||
| Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 | Q28254493 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy | Q28259779 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6 | Q28267337 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
| Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 | ||
| siRNA and miRNA: an insight into RISCs | Q28305768 | ||
| Dicer is essential for mouse development | Q28511142 | ||
| Towards safe, non-viral therapeutic gene expression in humans. | Q36068277 | ||
| mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer | Q36103305 | ||
| MicroRNAs in vertebrate development | Q36175229 | ||
| RNAi based approaches to the treatment of malignant glioma | Q36478665 | ||
| Toxicity in mice expressing short hairpin RNAs gives new insight into RNAi | Q36581744 | ||
| Epigenetics and microRNAs | Q36783160 | ||
| Methylation of human microRNA genes in normal and neoplastic cells. | Q36800821 | ||
| MicroRNAs and haematology: small molecules, big function | Q36835898 | ||
| Argonaute proteins: mediators of RNA silencing | Q36845844 | ||
| MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth | Q38298486 | ||
| MicroRNA expression profiles in head and neck cancer cell lines | Q38302158 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma | Q38309711 | ||
| Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer | Q38314320 | ||
| Codelivery of NF-kappaB decoy-related oligodeoxynucleotide improves LPD-mediated systemic gene transfer | Q38359365 | ||
| Microarray-based, high-throughput gene expression profiling of microRNAs | Q38443466 | ||
| Detection of let-7a microRNA by real-time PCR in gastric carcinoma. | Q39595492 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| Downregulation of microRNAs-143 and -145 in B-cell malignancies | Q40076849 | ||
| Regulation of p27Kip1 by miRNA 221/222 in glioblastoma | Q40089204 | ||
| Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells | Q40123026 | ||
| The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. | Q40169748 | ||
| Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b | Q40207487 | ||
| Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. | Q40223962 | ||
| Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis | Q40250297 | ||
| Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery | Q40330639 | ||
| Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma. | Q40422274 | ||
| Reduced expression of Dicer associated with poor prognosis in lung cancer patients. | Q43573248 | ||
| RNAi in human cells: basic structural and functional features of small interfering RNA. | Q44199577 | ||
| Cationic liposome-mediated delivery of siRNAs in adult mice | Q47346869 | ||
| Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 | ||
| Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. | Q51562160 | ||
| Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. | Q51958786 | ||
| MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. | Q52582850 | ||
| Erk5 is activated and acts as a survival factor in mitosis. | Q53541523 | ||
| A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. | Q53582529 | ||
| The RNAi revolution. | Q55038521 | ||
| Characterization of colorectal-cancer-related cDNA clones obtained by subtractive hybridization screening | Q56566983 | ||
| A guide through present computational approaches for the identification of mammalian microRNA targets | Q61161512 | ||
| Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro | Q62061836 | ||
| Gene silencing by systemic delivery of synthetic siRNAs in adult mice | Q73166515 | ||
| Literature red in tooth and claw | Q74197554 | ||
| Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung | Q74427809 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 | ||
| Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
| Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs | Q29547837 | ||
| A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors | Q29614399 | ||
| MicroRNAs direct rapid deadenylation of mRNA | Q29614566 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues | Q29619171 | ||
| Transcriptional activation of miR-34a contributes to p53-mediated apoptosis | Q29619556 | ||
| Activation of the interferon system by short-interfering RNAs | Q29620341 | ||
| Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
| Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster | Q29620726 | ||
| Illuminating the silence: understanding the structure and function of small RNAs | Q29622905 | ||
| Inducible microRNA expression by an all-in-one episomal vector system | Q30826808 | ||
| miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. | Q31115813 | ||
| Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. | Q33706258 | ||
| Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs | Q33780723 | ||
| Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation | Q34115911 | ||
| siRNA-mediated gene silencing in vitro and in vivo. | Q34150604 | ||
| MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 | ||
| Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? | Q34455538 | ||
| Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways | Q34530552 | ||
| Expression profiling identifies microRNA signature in pancreatic cancer | Q34588109 | ||
| Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma | Q34647028 | ||
| MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle | Q34698100 | ||
| MYCN regulates oncogenic MicroRNAs in neuroblastoma | Q34702713 | ||
| Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 | ||
| MicroRNAs and cancer | Q35561593 | ||
| Oncolytic viral therapies | Q35852258 | ||
| Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing | Q35865083 | ||
| MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets | Q35951484 | ||
| Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs | Q35961201 | ||
| The role of small RNAs in human diseases: potential troublemaker and therapeutic tools | Q36002359 | ||
| P433 | issue | 6 | |
| P921 | main subject | gene therapy | Q213901 |
| cancer gene therapy | Q124350675 | ||
| P304 | page(s) | 341-355 | |
| P577 | publication date | 2008-03-28 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? | |
| P478 | volume | 15 |
| Q47860853 | A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model |
| Q34100430 | A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia |
| Q21134995 | A systematic screen for micro-RNAs regulating the canonical Wnt pathway |
| Q84943840 | Aberrant microRNA expression and its implications in the pathogenesis of leukemias |
| Q34127590 | Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus |
| Q39857515 | Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method. |
| Q39829122 | BMPRII is a direct target of miR-21. |
| Q38686015 | Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer |
| Q37586623 | CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity |
| Q37640235 | Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases |
| Q85174013 | Cellular context in epigenetics: quantitative multicolor imaging and automated per-cell analysis of miRNAs and their putative targets |
| Q36557246 | Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy |
| Q45612220 | Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma |
| Q55010478 | Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer. |
| Q37383058 | Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development |
| Q33555616 | Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs. |
| Q95841100 | Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer |
| Q50131778 | Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates. |
| Q36204131 | Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers |
| Q54434780 | Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. |
| Q28285980 | Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 |
| Q34990488 | Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage |
| Q34168267 | ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer |
| Q46584676 | Efficient in vivo microRNA targeting of liver metastasis |
| Q37723147 | Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? |
| Q37572446 | Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells |
| Q35445305 | Evaluation and identification of microRNA-106 in the diagnosis of cancer: a meta-analysis |
| Q33980036 | Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. |
| Q37902256 | Expression of microRNAs: potential molecular link between obesity, diabetes and cancer |
| Q38934949 | Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis |
| Q35853925 | Ghrelin inhibition of ethanol-induced gastric epithelial cell apoptosis is mediated by miR-21. |
| Q39084265 | HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery |
| Q34924245 | Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy |
| Q34192667 | High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. |
| Q35044328 | Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism |
| Q43234497 | Identification of the potential target genes of microRNA-146a induced by PMA treatment in human microvascular endothelial cells |
| Q33719798 | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship |
| Q34275371 | Leukaemogenesis: more than mutant genes |
| Q39125361 | Machine Learning Approaches Toward Building Predictive Models for Small Molecule Modulators of miRNA and Its Utility in Virtual Screening of Molecular Databases. |
| Q44139838 | MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma |
| Q37238372 | MiRNAs, epigenetics, and cancer |
| Q42130298 | MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis |
| Q38178272 | MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas |
| Q61999299 | MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer |
| Q52721976 | MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets. |
| Q38018308 | MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy |
| Q26775937 | MicroRNA in inflammatory bowel disease: Translational research and clinical implication |
| Q39925866 | MicroRNA profile analysis of human prostate cancers |
| Q37208449 | MicroRNA profiling and head and neck cancer |
| Q50559150 | MicroRNA-139-5p Inhibit Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil Containing Protein Kinase 2 in Ovarian Cancer. |
| Q39455098 | MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma |
| Q36524687 | MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma |
| Q35949461 | MicroRNAs and Gastroenterological Cancers |
| Q36165889 | MicroRNAs and cardiovascular medicine |
| Q37431350 | MicroRNAs in cholangiociliopathies |
| Q37632608 | MicroRNAs in colorectal cancer: translation of molecular biology into clinical application |
| Q37344528 | MicroRNAs with a nucleolar location |
| Q42352599 | Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue |
| Q28478852 | Modeling of miRNA and drug action in the EGFR signaling pathway |
| Q38405337 | Multifunctional nucleic acids for tumor cell treatment. |
| Q64062045 | NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma |
| Q60045932 | Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93 |
| Q33899954 | Pancreatic cancer: molecular pathogenesis and new therapeutic targets |
| Q35002018 | Paradoxical microRNAs: individual gene repressors, global translation enhancers |
| Q55463671 | Potential role of miRNAs and their inhibitors in glioma treatment. |
| Q37780603 | Potential use of RNA interference in cancer therapy |
| Q37448777 | Rational design of microRNA-siRNA chimeras for multifunctional target suppression. |
| Q48738053 | Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid. |
| Q39756001 | Regulating A549 cells growth by ASO inhibiting miRNA expression |
| Q34089030 | Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis |
| Q39359216 | Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity |
| Q36844904 | Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience |
| Q33586833 | Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death |
| Q37653706 | Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs |
| Q28067449 | Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer |
| Q36299692 | Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge |
| Q36419685 | Spatiotemporal control of microRNA function using light-activated antagomirs. |
| Q34428766 | The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms. |
| Q33436471 | The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma |
| Q34220723 | The clinical potential of microRNAs |
| Q37204707 | The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster |
| Q37768337 | The function of microRNAs, small but potent molecules, in human prostate cancer. |
| Q24606673 | The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease |
| Q36685520 | The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma |
| Q46061011 | The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer |
| Q24629056 | The role of miR-26 in tumors and normal tissues (Review) |
| Q37946457 | The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. |
| Q39091713 | The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma |
| Q33794911 | Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer |
| Q34599246 | Toward microRNA-based therapeutics for heart disease: the sense in antisense |
| Q38808653 | Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R. |
| Q53309914 | Up-regulation of microRNA in bladder tumor tissue is not common. |
| Q37371867 | Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function |
| Q42026232 | VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma |
| Q24634704 | miR-145-mediated suppression of cell growth, invasion and metastasis |
| Q42322707 | miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo |
| Q36926211 | miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. |
| Q37144049 | miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells |
| Q39878284 | miR-449a targets HDAC-1 and induces growth arrest in prostate cancer |
| Q91653574 | miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential |
| Q34947386 | miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein |
| Q26824561 | miRNAs in breast cancer tumorigenesis (Review) |
Search more.